Abstract 698: The Structurally Engineered Fatty Acid, Icosabutate, Improves Lipid Metabolism and Reduces Severity of Atherogenesis in Mice

Geurt Stokman, Anita M. van den Hoek,Elsbet J. Pieterman,José W.A. van der Hoorn,Tore Skjaeret,David A. Fraser,Hans M.G. Princen

Arteriosclerosis, Thrombosis, and Vascular Biology（2019）

引用 0|浏览1

暂无评分

摘要

Icosabutate is a structurally engineered fatty acid derived from eicosapentaenoic acid (EPA) which decreases plasma triglycerides (TG) and non-HDL lipoprotein cholesterol (VLDL-C and LDL-C) in hype...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要